ADVFN - Advanced Financial Network.
HOME» NASDAQ » M » MYL Stock Price » MYL Stock News

Mylan Inc. Share News

 Mylan Inc. (mm) Stock Price
MYL Stock Price
 Mylan Inc. (mm) Stock Chart
MYL Stock Chart
 Mylan Inc. (mm) Stock News
MYL Stock News
 Mylan Inc. (mm) Company Information
MYL Company Information
 Mylan Inc. (mm) Stock Trades
MYL Stock Trades

Mylan Confirms Endo Suit Over Generic Migraine Drug Application

DOW JONES NEWSWIRES Mylan Inc. (MYL) confirmed Wednesday that it has been sued by Endo Pharmaceuticals Holdings Inc. (ENDP) over its application for approval of a generic drug used to treat acute migraine headaches in adults. Mylan--one of the world's largest generic drug makers--said it believes it is the first company to file a substantially complete application for approval of frovatriptan succinate EQ, a generic version of Frova. The company said it expects to qualify for 180 days of marketing exclusivity upon final approval from the Food and Drug Administration. Mylan, which has had litigation-related charges figure prominently in its recent quarterly results, last month reported second-quarter earnings surged 70% as sales got a lift from a weaker dollar. Shares closed Tuesday at $20.01 and were inactive in recent premarket trade. Through the latest close, the stock is down 5.3% since the start of the year. -By Mia Lamar, Dow Jones Newswires; 212-416-3207; mia.lamar@dowjones.com

Stock News for Mylan Inc. (MYL)
DateTimeHeadline
04/04/201416:59:07MARKET SNAPSHOT: U.S. Stocks Sell Off; Nasdaq Drop Worst In 2...
04/04/201415:28:10MARKET SNAPSHOT: Nasdaq Risks Worst Day In 2 Months As High-flyers...
04/04/201412:24:06MARKET SNAPSHOT: U.S. Stocks Turn Lower; Nasdaq Down 1.4%
04/04/201411:15:12MARKET SNAPSHOT: U.S. Stocks Edge Higher On Steady Jobs Growth
04/04/201411:11:18MARKET SNAPSHOT: U.S. Stocks Edge Higher; Dow Hits Intraday Record
03/27/201409:44:41U.S. Hot Stocks: Hot Stocks to Watch
03/27/201408:30:40Mylan Says It Won Contract-Breach Case Against GlaxoSmithKline
03/24/201416:56:39MARKET SNAPSHOT: U.S. Stocks Fall; Nasdaq Skids 1.2%
03/24/201415:34:51MARKET SNAPSHOT: Stocks Fall; Nasdaq Set For Biggest Loss In...
03/13/201407:23:08Mylan Plans to Start Selling Generic Celebrex in May
02/27/201416:39:15MARKET SNAPSHOT: U.S. Stock Gains Push S&P 500 To Record
02/27/201413:13:06MARKET SNAPSHOT: U.S. Stocks Rise; S&P 500 Eyes 1,850 Record
02/27/201410:58:13MARKET SNAPSHOT: U.S. Stocks Volatile; Yellen Speaks Before Senate
02/21/201417:42:43Pfizer Will Resume Shipping Thyroid Drug
01/14/201406:11:37Valeant, Actavis, Mylan Said Interested in Buying Pfizer's Generics...
11/15/201309:10:28Caxton Associates LP 3Q 13F: Largest Purchases
11/15/201309:10:28Caxton Associates LP 3Q 13F: Holdings As Of Sep 30 -2-
11/15/201309:10:27Caxton Associates LP 3Q 13F: Holdings As Of Sep 30
11/15/201308:22:24Janus Capital Management 3Q 13F: Holdings As Of -2-
11/15/201308:22:23Janus Capital Management 3Q 13F: Holdings As Of Sep 30

Mylan Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad